JPY 2341.0
(1.56%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 13.51 Billion JPY | -1.62% |
2022 | 13.74 Billion JPY | 2.57% |
2021 | 13.39 Billion JPY | -5.07% |
2020 | 14.11 Billion JPY | 10.24% |
2019 | 12.8 Billion JPY | -4.68% |
2018 | 13.42 Billion JPY | 1.19% |
2017 | 13.27 Billion JPY | 0.17% |
2016 | 13.24 Billion JPY | 5.56% |
2015 | 12.55 Billion JPY | -3.42% |
2014 | 12.99 Billion JPY | -11.48% |
2013 | 14.68 Billion JPY | -4.15% |
2012 | 15.31 Billion JPY | 25.6% |
2011 | 12.19 Billion JPY | -11.7% |
2010 | 13.81 Billion JPY | -0.63% |
2009 | 13.89 Billion JPY | 0.4% |
2008 | 13.84 Billion JPY | 9.5% |
2007 | 12.64 Billion JPY | -3.97% |
2006 | 13.16 Billion JPY | -4.3% |
2005 | 13.75 Billion JPY | 0.07% |
2004 | 13.74 Billion JPY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 4.17 Billion JPY | 33.28% |
2023 Q2 | 3.37 Billion JPY | -3.79% |
2023 Q1 | 3.5 Billion JPY | 12.7% |
2023 Q4 | 3.13 Billion JPY | -18.27% |
2023 FY | 13.51 Billion JPY | -1.62% |
2023 Q3 | 3.83 Billion JPY | 13.61% |
2022 Q2 | 3.52 Billion JPY | 0.2% |
2022 Q4 | 3.11 Billion JPY | -13.32% |
2022 Q1 | 3.51 Billion JPY | 16.68% |
2022 Q3 | 3.58 Billion JPY | 1.79% |
2022 FY | 13.74 Billion JPY | 2.57% |
2021 Q4 | 3.01 Billion JPY | -16.32% |
2021 FY | 13.39 Billion JPY | -5.07% |
2021 Q3 | 3.6 Billion JPY | 8.72% |
2021 Q1 | 3.46 Billion JPY | 19.48% |
2021 Q2 | 3.31 Billion JPY | -4.36% |
2020 Q4 | 2.9 Billion JPY | -24.4% |
2020 Q1 | 3.75 Billion JPY | 32.39% |
2020 Q2 | 3.62 Billion JPY | -3.62% |
2020 FY | 14.11 Billion JPY | 10.24% |
2020 Q3 | 3.83 Billion JPY | 5.97% |
2019 FY | 12.8 Billion JPY | -4.68% |
2019 Q4 | 2.83 Billion JPY | -17.22% |
2019 Q2 | 3.11 Billion JPY | -8.75% |
2019 Q1 | 3.41 Billion JPY | 14.58% |
2019 Q3 | 3.42 Billion JPY | 9.87% |
2018 Q3 | 3.68 Billion JPY | 8.03% |
2018 FY | 13.42 Billion JPY | 1.19% |
2018 Q1 | 3.34 Billion JPY | 9.89% |
2018 Q2 | 3.41 Billion JPY | 2.0% |
2018 Q4 | 2.98 Billion JPY | -19.09% |
2017 Q1 | 3.31 Billion JPY | 8.23% |
2017 FY | 13.27 Billion JPY | 0.17% |
2017 Q3 | 3.58 Billion JPY | 7.66% |
2017 Q2 | 3.32 Billion JPY | 0.39% |
2017 Q4 | 3.04 Billion JPY | -15.02% |
2016 Q1 | 3.48 Billion JPY | 26.63% |
2016 FY | 13.24 Billion JPY | 5.56% |
2016 Q4 | 3.06 Billion JPY | -12.23% |
2016 Q3 | 3.49 Billion JPY | 8.72% |
2016 Q2 | 3.21 Billion JPY | -7.92% |
2015 FY | 12.55 Billion JPY | -3.42% |
2015 Q4 | 2.75 Billion JPY | -19.24% |
2015 Q3 | 3.4 Billion JPY | 7.27% |
2015 Q2 | 3.17 Billion JPY | -1.03% |
2015 Q1 | 3.21 Billion JPY | 8.04% |
2014 Q3 | 3.58 Billion JPY | 11.94% |
2014 Q4 | 2.97 Billion JPY | -16.98% |
2014 FY | 12.99 Billion JPY | -11.48% |
2014 Q1 | 3.24 Billion JPY | 1.37% |
2014 Q2 | 3.19 Billion JPY | -1.48% |
2013 Q2 | 3.6 Billion JPY | -6.7% |
2013 Q4 | 3.2 Billion JPY | -20.15% |
2013 FY | 14.68 Billion JPY | -4.15% |
2013 Q1 | 3.86 Billion JPY | 14.52% |
2013 Q3 | 4.01 Billion JPY | 11.23% |
2012 Q3 | 4.21 Billion JPY | 12.27% |
2012 Q4 | 3.37 Billion JPY | -20.01% |
2012 Q1 | 3.96 Billion JPY | 40.33% |
2012 FY | 15.31 Billion JPY | 25.6% |
2012 Q2 | 3.75 Billion JPY | -5.29% |
2011 Q1 | 2.83 Billion JPY | -8.24% |
2011 Q2 | 3.16 Billion JPY | 11.49% |
2011 Q3 | 3.36 Billion JPY | 6.35% |
2011 Q4 | 2.82 Billion JPY | -15.99% |
2011 FY | 12.19 Billion JPY | -11.7% |
2010 Q3 | 3.82 Billion JPY | 6.07% |
2010 Q2 | 3.61 Billion JPY | 10.09% |
2010 FY | 13.81 Billion JPY | -0.63% |
2010 Q4 | 3.09 Billion JPY | -19.22% |
2010 Q1 | 3.27 Billion JPY | 7.93% |
2009 Q1 | 3.62 Billion JPY | 19.25% |
2009 Q4 | 3.03 Billion JPY | -16.45% |
2009 Q3 | 3.63 Billion JPY | 0.97% |
2009 Q2 | 3.6 Billion JPY | -0.63% |
2009 FY | 13.89 Billion JPY | 0.4% |
2008 Q2 | 3.42 Billion JPY | 0.0% |
2008 FY | 13.84 Billion JPY | 9.5% |
2008 Q4 | 3.03 Billion JPY | -20.94% |
2008 Q3 | 3.84 Billion JPY | 12.1% |
2007 FY | 12.64 Billion JPY | -3.97% |
2006 FY | 13.16 Billion JPY | -4.3% |
2005 FY | 13.75 Billion JPY | 0.07% |
2004 FY | 13.74 Billion JPY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 72.274% |
Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 99.381% |
Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 92.809% |
Shionogi & Co., Ltd. | 369.08 Billion JPY | 96.338% |
Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -281.745% |
Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 86.067% |
Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 64.636% |
Eisai Co., Ltd. | 586.41 Billion JPY | 97.695% |
Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -125.358% |
Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 82.884% |
Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 74.041% |
Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -74.683% |
Tsumura & Co. | 68.81 Billion JPY | 80.358% |
Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | 63.801% |
Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | 45.478% |
Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 83.391% |
Fuji Pharma Co., Ltd. | 16.51 Billion JPY | 18.153% |
Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 73.064% |
KYORIN Holdings, Inc. | 51.4 Billion JPY | 73.702% |
Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -1152.734% |
Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -37.382% |
SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -206.437% |
MedRx Co., Ltd | 26 Million JPY | -51888.462% |
Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -68.421% |
Solasia Pharma K.K. | 337 Million JPY | -3910.979% |
Modalis Therapeutics Corporation | -731 Thousand JPY | 1849210.807% |
ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | 55.92% |
Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 75.116% |
Cyfuse Biomedical K.K. | 37.74 Million JPY | -35712.315% |
Toho Holdings Co., Ltd. | 112.98 Billion JPY | 88.036% |
Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -103.581% |